Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2026-01-25 @ 12:16 AM
Study NCT ID:
NCT05618366
Status:
RECRUITING
Last Update Posted:
2025-04-08
First Post:
2022-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
Sponsor:
Organization: